Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6526153rdf:typepubmed:Citationlld:pubmed
pubmed-article:6526153lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6526153lifeskim:mentionsumls-concept:C0305062lld:lifeskim
pubmed-article:6526153lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:6526153lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:6526153pubmed:dateCreated1985-3-28lld:pubmed
pubmed-article:6526153pubmed:abstractTextSuccessful hybridization has been obtained between PWM stimulated peripheral blood lymphocytes from tetanus toxoid immunized donors and the human B lymphoma line RH-L-4. Among the hybrids selected after cloning, the average in vitro activity against tetanus toxoid was 1-5 micrograms/10(6) cells/24 hours. The specific activity of one of them was further tested in vitro (RIA) and in vivo (mouse protection test) and compared favourably with a human polyclonal antitetanus globulin.lld:pubmed
pubmed-article:6526153pubmed:languageenglld:pubmed
pubmed-article:6526153pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6526153pubmed:citationSubsetIMlld:pubmed
pubmed-article:6526153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6526153pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6526153pubmed:statusMEDLINElld:pubmed
pubmed-article:6526153pubmed:issn0301-5149lld:pubmed
pubmed-article:6526153pubmed:authorpubmed-author:OlssonLLlld:pubmed
pubmed-article:6526153pubmed:authorpubmed-author:ArmandJJlld:pubmed
pubmed-article:6526153pubmed:authorpubmed-author:Vincent-Falqu...lld:pubmed
pubmed-article:6526153pubmed:authorpubmed-author:MazauricTTlld:pubmed
pubmed-article:6526153pubmed:issnTypePrintlld:pubmed
pubmed-article:6526153pubmed:volume57lld:pubmed
pubmed-article:6526153pubmed:ownerNLMlld:pubmed
pubmed-article:6526153pubmed:authorsCompleteYlld:pubmed
pubmed-article:6526153pubmed:pagination87-91lld:pubmed
pubmed-article:6526153pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:meshHeadingpubmed-meshheading:6526153-...lld:pubmed
pubmed-article:6526153pubmed:year1984lld:pubmed
pubmed-article:6526153pubmed:articleTitleA human monoclonal antibody specific for tetanus toxoid.lld:pubmed
pubmed-article:6526153pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6526153pubmed:publicationTypeComparative Studylld:pubmed